1. Molecular characterization of capsular polysaccharides and surface protein genes in relation to genetic similarity of group B streptococci isolated from Polish pregnant women
- Author
-
Tomasz Gosiewski, Malgorzata Bodaszewska-Lubas, Paweł Adamski, Monika Brzychczy-Włoch, and Piotr B Heczko
- Subjects
Adult ,DNA, Bacterial ,Serotype ,Genotype ,Epidemiology ,Biology ,Polymerase Chain Reaction ,Group B ,Streptococcus agalactiae ,Microbiology ,law.invention ,Bacterial Proteins ,Pregnancy ,law ,Genetic variation ,Pulsed-field gel electrophoresis ,Humans ,Serotyping ,Genotyping ,Bacterial Capsules ,Phylogeny ,Polymerase chain reaction ,Genetic heterogeneity ,Rectum ,Genetic Variation ,Membrane Proteins ,Molecular biology ,Electrophoresis, Gel, Pulsed-Field ,Infectious Diseases ,Carrier State ,Vagina ,Female ,Poland - Abstract
SUMMARYSerotyping, subtyping and genotyping are important tools for epidemiological studies of group B streptococci (GBS). We investigated the genotype distribution of 353 GBS isolates originating from vaginal or rectal carriage to identify capsular serotypes and subtypes based on the surface protein genes of the alpha-like protein (Alp) family. GBS were recovered from 30% of 1176 pregnant women during the period 2007–2009, with a predominance of capsular genotypes III (35%), Ia (20%), V (17%), II (15%), Ib (8%) and IV (5%). The most common Alp gene wasepsilon(26%), followed byrib(22%),alp2(21%),bca(17%) andalp3(14%). Several protein genes were significantly associated (G2=249·635,Pepsilonwith Ia, Ib, IV;bcawith Ib, II;ribwith II, III;alp3with V;alp2with III. High genetic diversity within GBS strains was observed using DNA macrorestriction. Serotypes Ib, II and III demonstrated the greatest genetic heterogeneity and serotype V the lowest heterogeneity (relative frequency coefficient ⩾0·03vs. −0·46, respectively). Macrolide-resistant strains with serotype V andalp3gene, showed higher uniformity in genetic profile. The distribution of serotypes and surface proteins of GBS strains are necessary data to inform the design and formulation of new GBS vaccines for use in Poland and other countries.
- Published
- 2011
- Full Text
- View/download PDF